AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26852216 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 kVp CTP (Group B)
Number of subjects: 150
Study 26852216 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 kVp CTP (Group C)
Number of subjects: 150
Study 26852216 — intervention group
Group type: COMPARATOR
Intervention: 80 kVp CTP (Group A)
Number of subjects: 150
Study 24621174 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgical Reduction and Internal Fixation (ORIF)
Number of subjects: 620
Study 24621174 — intervention group
Group type: COMPARATOR
Intervention: Close Contact Casting (CCC)
Number of subjects: 620
Study 24621174 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ORIF and CCC
Number of subjects: 620
Study 23035669 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a physical activity intervention (supervised exercise on a treadmill plus PA consultations)
Number of subjects: 0
Study 23035669 — intervention group
Group type: COMPARATOR
Intervention: Usual care (behavioral support for smoking cessation)
Number of subjects: 0
Study 23035669 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a physical activity intervention
Number of subjects: 0
Study 23035669 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 21280519 — intervention group
Group type: EXPERIMENTAL
Intervention: Lercanidipine 10 mg/d
Number of subjects: 80
Study 21280519 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg/d
Number of subjects: 80
Study 17174527 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine
Number of subjects: 0
Study 17174527 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl
Number of subjects: 0
Study 17174527 — intervention group
Group type: COMPARATOR
Intervention: Patient controlled intravenous analgesia (PCIA) with piritramide
Number of subjects: 0
Study 17174527 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine or fentanyl
Number of subjects: 0
Study 17174527 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EDA)
Number of subjects: 0
Study 15609028 — intervention group
Group type: EXPERIMENTAL
Intervention: ECCE (maximal eccentric elbow flexions)
Number of subjects: 8
Study 15609028 — intervention group
Group type: COMPARATOR
Intervention: CONE (maximal concentric elbow flexions)
Number of subjects: 8
Study 15609028 — intervention group
Group type: EXPERIMENTAL
Intervention: ECCE
Number of subjects: 8
Study 12480851 — intervention group
Group type: EXPERIMENTAL
Intervention: Early computed tomography (within 24 hours of admission)
Number of subjects: 120
Study 12480851 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (radiological investigations as indicated)
Number of subjects: 120
Study 9796489 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CO2 laser irradiation and fluoridation with stannous fluoride gel
Number of subjects: 0
Study 9796489 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoridation
Number of subjects: 0
Study 9796489 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CO2 laser irradiation and fluoridation
Number of subjects: 0
Study 7894325 — intervention group
Group type: EXPERIMENTAL
Intervention: PCNA labeling index (LI)
Number of subjects: 54
Study 7894325 — intervention group
Group type: EXPERIMENTAL
Intervention: BrdUrd labeling index (LI)
Number of subjects: 54
Study 7894325 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of PCNA and BrdUrd LIs
Number of subjects: 54
Study 2489541 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum containing mace extract
Number of subjects: 68
Study 2489541 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum containing egg-white lysozyme
Number of subjects: 68
Study 2489541 — intervention group
Group type: COMPARATOR
Intervention: Control group (chewing gum without mace extract or egg-white lysozyme)
Number of subjects: 68
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental diamond discs
Number of subjects: 20
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M discs
Number of subjects: 20
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: Rough corundum discs
Number of subjects: 20
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: Polishing paste
Number of subjects: 20
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfinished and sealed surfaces
Number of subjects: 20
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealed surfaces and surfaces finished by the matrix alone
Number of subjects: 20
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: All finishing methods
Number of subjects: 20
Study 272042 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptic surfaces
Number of subjects: 20
Study 31196137 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual waiver care with internal facilitation of the implementation strategies
Number of subjects: 15000
Study 31196137 — intervention group
Group type: COMPARATOR
Intervention: Usual waiver care with both internal and external facilitation of the implementation strategies
Number of subjects: 15000
Study 31196137 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention addressing individual's capabilities and home environment
Number of subjects: 15000
Study 31196137 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention effects on primary outcomes
Number of subjects: 15000
Study 28603306 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive supervision after a WHO training course for 1 year
Number of subjects: 4626
Study 28603306 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4626
Study 26559269 — intervention group
Group type: EXPERIMENTAL
Intervention: Simo Decoction (SMD) and acupuncture
Number of subjects: 162
Study 26559269 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 162
Study 26559269 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 162
Study 22563790 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term psychodynamic psychotherapy
Number of subjects: 326
Study 22563790 — intervention group
Group type: COMPARATOR
Intervention: Short-term psychodynamic psychotherapy
Number of subjects: 326
Study 22563790 — intervention group
Group type: COMPARATOR
Intervention: Solution-focused therapy
Number of subjects: 326
Study 21819751 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6% olopatadine
Number of subjects: 22
Study 21819751 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 22
Study 20084974 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabipur produced in India
Number of subjects: 0
Study 20084974 — intervention group
Group type: COMPARATOR
Intervention: Rabipur produced in Germany
Number of subjects: 0
Study 16680285 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy session with classical music for 30 minutes
Number of subjects: 84
Study 16680285 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 84
Study 15294368 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day clomiphene citrate (CC) regimen (50mg per day for 3 days)
Number of subjects: 59
Study 15294368 — intervention group
Group type: COMPARATOR
Intervention: 5-day clomiphene citrate (CC) regimen (50mg per day for 5 days)
Number of subjects: 59
Study 11478142 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose MPA (600 mg/day) for over 8 weeks
Number of subjects: 14
Study 11478142 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic administrations of low-dose MPA after high-dose MPA
Number of subjects: 14
Study 11478142 — intervention group
Group type: EXPERIMENTAL
Intervention: MPA as adjuvant therapy after complete operations and whole pelvic irradiation
Number of subjects: 14
Study 11478142 — intervention group
Group type: EXPERIMENTAL
Intervention: MPA in combination with chemotherapy (CAP)
Number of subjects: 14
Study 11194002 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 46
Study 8859724 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) combination therapy
Number of subjects: 20
Study 8859724 — intervention group
Group type: COMPARATOR
Intervention: Interferon-gamma (IFN-gamma) alone
Number of subjects: 20
Study 8859724 — intervention group
Group type: COMPARATOR
Intervention: Combination treatment of tumor-infiltrating lymphocytes (TIL), IL-2, and IFN-gamma
Number of subjects: 20
Study 1995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (10 micrograms/kg intravenously)
Number of subjects: 10
Study 1995262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon distension at proximal site
Number of subjects: 10
Study 1995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon distension at distal site
Number of subjects: 10
Study 6189074 — intervention group
Group type: COMPARATOR
Intervention: DVI pacing
Number of subjects: 50
Study 6189074 — intervention group
Group type: COMPARATOR
Intervention: VDD/DDD pacing
Number of subjects: 50
Study 31961420 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation plus renal denervation
Number of subjects: 302
Study 31961420 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary vein isolation alone
Number of subjects: 302
Study 31961420 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 302
Study 30609099 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy for insomnia (n=106)
Number of subjects: 159
Study 30609099 — intervention group
Group type: COMPARATOR
Intervention: Attention control (n=53)
Number of subjects: 159
Study 29543805 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated screening (ITS) with pyrethroid-impregnated long-lasting insecticide-treated netting material installed on external doors and windows.
Number of subjects: 844
Study 29543805 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 844
Study 27136744 — intervention group
Group type: EXPERIMENTAL
Intervention: GEMOX plus cetuximab
Number of subjects: 80
Study 27136744 — intervention group
Group type: COMPARATOR
Intervention: GEMOX
Number of subjects: 80
Study 24577747 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (sleep‐related behavior modification and progressive muscle relaxation) for 3 months
Number of subjects: 103
Study 22168538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg single dose
Number of subjects: 26
Study 22168538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg single dose
Number of subjects: 26
Study 20645951 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1 μg.kg(‐1)
Number of subjects: 100
Study 20645951 — intervention group
Group type: COMPARATOR
Intervention: Intranasal placebo (0.9% saline)
Number of subjects: 100
Study 17685853 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized tgAAVCF (1x10^13 DNase-resistant particles), n=51
Number of subjects: 102
Study 17685853 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo, n=51
Number of subjects: 102
Study 16670047 — intervention group
Group type: EXPERIMENTAL
Intervention: Life and death studies (LDS) program (13-week course including lectures, video appraisal, games, simulations, films, books, assignments, and group sharing)
Number of subjects: 96
Study 16670047 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 96
Study 12236605 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10349190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (25 micrograms)
Number of subjects: 9
Study 10349190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (50 micrograms)
Number of subjects: 9
Study 10349190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (100 micrograms)
Number of subjects: 9
Study 10349190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (200 micrograms)
Number of subjects: 9
Study 8745497 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of glucose controlled by pump
Number of subjects: 336
Study 8745497 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 336
Study 2665553 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol stimuli
Number of subjects: 24
Study 2665553 — intervention group
Group type: EXPERIMENTAL
Intervention: Pepper juice stimuli
Number of subjects: 24
Study 2665553 — intervention group
Group type: COMPARATOR
Intervention: Water stimuli
Number of subjects: 24
Study 2665553 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic subjects
Number of subjects: 24
Study 31228427 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 134
Study 31228427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 28719708 — intervention group
Group type: EXPERIMENTAL
Intervention: PlasmaBlade
Number of subjects: 20
Study 28719708 — intervention group
Group type: COMPARATOR
Intervention: Cold dissection
Number of subjects: 20
Study 25735650 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strategy intervention to support clubs to implement responsible alcohol management practices
Number of subjects: 87
Study 25735650 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 87
Study 23228884 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal phototherapy
Number of subjects: 77
Study 23228884 — intervention group
Group type: COMPARATOR
Intervention: Azelastine
Number of subjects: 77
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Cold Containment System (ECCS)
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice Buckets (IB)
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice Towels (IT)
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Shade
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Port‐a‐Cool® (FAN)
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehab. Hood® (HOOD)
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Game Ready Active Cooling Vest™ (GRV)
Number of subjects: 16
Study 21760549 — intervention group
Group type: EXPERIMENTAL
Intervention: Nike Ice Vest™ (NIV)
Number of subjects: 16
Study 21760549 — intervention group
Group type: COMPARATOR
Intervention: Control (SUN)
Number of subjects: 16
Study 19390448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-Controlled Ventilation (PCV)
Number of subjects: 90
Study 19390448 — intervention group
Group type: COMPARATOR
Intervention: Manual-Controlled Ventilation (MCV)
Number of subjects: 90
Study 19390448 — intervention group
Group type: COMPARATOR
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 90
Study 16775552 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU of vitamin E + 1 g of vitamin C (V; N=15)
Number of subjects: 48
Study 16775552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit and vegetable juice powder concentrate (FV; N=16)
Number of subjects: 48
Study 16775552 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P; N=17)
Number of subjects: 48
Study 16294572 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive community treatment
Number of subjects: 98
Study 16294572 — intervention group
Group type: COMPARATOR
Intervention: Integrated assertive community treatment
Number of subjects: 98
Study 11524344 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaraminol infusion (0.25 mg/min, titrated)
Number of subjects: 66
Study 11524344 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no bolus)
Number of subjects: 66
Study 11524344 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (no significant difference)
Number of subjects: 66
Study 9311323 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-practice intervention involving a summary of completed pain scales reviewed by oncologists before evaluation.
Number of subjects: 320
Study 9311323 — intervention group
Group type: COMPARATOR
Intervention: Control group without the summary of pain scales.
Number of subjects: 320
Study 9311323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Management Index (PMI) measurement.
Number of subjects: 320
Study 8513520 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 100 micrograms intraoperatively, self-administered maximum of two epidural fentanyl boluses 50 micrograms (10 micrograms.ml‐1) with a lockout period of five minutes for a maximum of two doses per hour.
Number of subjects: 23
Study 8513520 — intervention group
Group type: COMPARATOR
Intervention: Single bolus of epidural morphine 3 mg (0.5 mg.ml‐1) intraoperatively, with PCA devices filled with 0.9% NaCl.
Number of subjects: 23
Study 3423310 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity controlled exercise (experimental group, n = 20)
Number of subjects: 38
Study 3423310 — intervention group
Group type: COMPARATOR
Intervention: Typical intensity exercise (control group, n = 18)
Number of subjects: 38
Study 30138718 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol) 1000 IU/day
Number of subjects: 1200
Study 30138718 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol) 2000 IU/day
Number of subjects: 1200
Study 30138718 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol) 4000 IU/day
Number of subjects: 1200
Study 30138718 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 (cholecalciferol) 200 IU/day
Number of subjects: 1200
Study 30138718 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 1200
Study 30138718 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Physical Performance Battery score
Number of subjects: 1200
Study 30138718 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity level (assessed by accelerometry)
Number of subjects: 1200
Study 30138718 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty score
Number of subjects: 1200
Study 28372335 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular insulin (40 IU daily for four months)
Number of subjects: 36
Study 28372335 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir (40 IU daily for four months)
Number of subjects: 36
Study 28372335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 26058676 — intervention group
Group type: EXPERIMENTAL
Intervention: New de-prescribing intervention involving pharmacists educating patients and prescribers, with a follow-up period of 1 year.
Number of subjects: 450
Study 26058676 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 450
Study 23168371 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 day per week training (EG1)
Number of subjects: 48
Study 23168371 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 days per week training (EG2)
Number of subjects: 48
Study 23168371 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 days per week training (EG3)
Number of subjects: 48
Study 23168371 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 20556262 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading group (60 implants)
Number of subjects: 71
Study 20556262 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading group (60 implants)
Number of subjects: 71
Study 18480688 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (4, 8, or 12 mg/d in fixed-dose study; 4-16 mg/d in flexible-dose trials)
Number of subjects: 0
Study 18480688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16878723 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers therapy
Number of subjects: 0
Study 16878723 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 12509593 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod liver oil (10 mL containing 1183 mg DHA)
Number of subjects: 590
Study 12509593 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (10 mL containing 4747 mg linoleic acid)
Number of subjects: 590
Study 11094013 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (1 mg/kg)
Number of subjects: 40
Study 11094013 — intervention group
Group type: COMPARATOR
Intervention: Thiopental (2 mg/kg)
Number of subjects: 40
Study 8891641 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic cortical stimulation
Number of subjects: 6
Study 1893647 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril
Number of subjects: 0
Study 6356323 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g twice daily)
Number of subjects: 251
Study 6356323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 30506899 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in evening blue light exposure (via blue-light-blocking glasses)
Number of subjects: 0
Study 30506899 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased morning light exposure (via the use of curtains)
Number of subjects: 0
Study 28710666 — intervention group
Group type: EXPERIMENTAL
Intervention: Information + action control text messages
Number of subjects: 121
Study 28710666 — intervention group
Group type: COMPARATOR
Intervention: Information only (Control)
Number of subjects: 121
Study 26658239 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diabetes therapy
Number of subjects: 1294
Study 24263388 — intervention group
Group type: EXPERIMENTAL
Intervention: 75‐mmHg continuous pressure with a silicone‐covered dressing
Number of subjects: 40
Study 24263388 — intervention group
Group type: COMPARATOR
Intervention: 125‐mmHg with a polyurethane foam dressing
Number of subjects: 40
Study 24015697 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea plus vitamin E (GTVE; 3 cups and 400 IU, respectively; n = 11)
Number of subjects: 22
Study 24015697 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 22
Study 20664489 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 58